Bioray Biotech Co FCF par action

Que fait Bioray Biotech Co ? BioRay Biotech Co., Ltd. generates revenue through its biological health products, functional medical testing services, and cell storage and preparation offerings. The company sells personalized probiotics, anti-allergic and intestinal probiotics, diabetes probiotics, female urinary tract products, and anti-arthritis probiotics. Functional medical testing includes personalized bacteria, personalized fungi, intestinal normal bacteria, quantitative magnesium detection in red blood cells, metabolic gene polymorphism analysis, and lymphocyte grouping. Cell storage services feature stem cell storage, immune cell storage, and cytokine induced killer (CIK) immune cell preparations. The primary customers for these products and services are individuals seeking personalized health solutions, including those managing chronic conditions like diabetes or arthritis. The company targets health-conscious consumers and medical professionals requiring specialized testing and cell-based therapies. BioRay Biotech focuses on delivering tailored health and medical services through its integrated product and service portfolio. Revenue streams are derived from direct sales of health products, testing service fees, and cell storage contracts. The business model emphasizes customization, with each product and service segment catering to specific health needs. The company’s offerings are structured to address individual health challenges through scientific and personalized approaches. Bioray Biotech Co est l'une des entreprises les plus populaires sur Eulerpool.